Parkinson's disease, considered the second most common degenerative disorder in adults, is a complex medical condition affecting the central nervous system, leading to the premature loss of dopamine-producing brain cells. Dopamine is a vital chemical for various bodily functions, and its deficiency results in symptoms ranging from motor problems such as tremors, rigidity, and slow movements to cognitive, sleep, and sensory disorders.

In response to this medical challenge, Cuba provides a groundbreaking treatment for Parkinson's disease that greatly enhances patients' quality of life. Through a unique surgical procedure known as selective dorsolateral subthalamotomy, the Caribbean nation has given hope to those facing this health condition.

With over a decade of experience in stereotactic procedures, the Cuban medical team comprises highly trained specialists who provide comprehensive and personalized care. From initial evaluation to treatment application, each patient receives a therapeutic approach tailored to their specific needs.

Candidates for this intervention are carefully selected based on various factors, including disease stage, presence of disabling symptoms, response to pharmacological treatments, and age. Once accepted, patients undergo an initial assessment to determine the most suitable therapeutic strategy. It is essential that each patient travels with a companion, ensuring a safe and effective process.

If you or a loved one is dealing with Parkinson's and seeking an effective solution, the Coordination and Processing Center of the Cuban Medical Services Commercialization, S.A., is available to provide detailed information and guidance throughout the process. You can contact them via email at smc@smcsalud.cu for specialized advice.

By: MSc. Dr. Patricia Alonso Galbán
Specialist in Marketing and Communication. CSMC, S.A.